These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15964894)
1. Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells. Medjane S; Raymond B; Wu Y; Touqui L Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L816-24. PubMed ID: 15964894 [TBL] [Abstract][Full Text] [Related]
2. Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. Kuwata H; Nakatani Y; Murakami M; Kudo I J Biol Chem; 1998 Jan; 273(3):1733-40. PubMed ID: 9430720 [TBL] [Abstract][Full Text] [Related]
3. Role of cytoplasmic and secretory phospholipase A2 in intestinal epithelial cell prostaglandin E2 formation. Grossman EM; Longo WE; Mazuski JE; Panesar N; Kaminski DL Int J Surg Investig; 2000; 1(6):467-76. PubMed ID: 11729854 [TBL] [Abstract][Full Text] [Related]
4. Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. Bidgood MJ; Jamal OS; Cunningham AM; Brooks PM; Scott KF J Immunol; 2000 Sep; 165(5):2790-7. PubMed ID: 10946311 [TBL] [Abstract][Full Text] [Related]
5. 12-HETE is a regulator of PGE Moreira V; Gutiérrez JM; Lomonte B; Vinolo MAR; Curi R; Lambeau G; Teixeira C Chem Biol Interact; 2020 Feb; 317():108903. PubMed ID: 31811862 [TBL] [Abstract][Full Text] [Related]
6. Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitis. Shoda J; Kano M; Asano T; Irimura T; Ueda T; Iwasaki R; Furukawa M; Kamiya J; Nimura Y; Todoroki T; Matsuzaki Y; Tanaka N Hepatology; 1999 Apr; 29(4):1026-36. PubMed ID: 10094942 [TBL] [Abstract][Full Text] [Related]
7. Regulation of prostaglandin synthesis in Madin Darby canine kidney cells: role of prostaglandin G/H synthase and secreted phospholipase A2. Schaefers HJ; Haselmann J; Goppelt-Struebe M Biochim Biophys Acta; 1996 May; 1300(3):197-202. PubMed ID: 8679684 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2. Murakami M; Kuwata H; Amakasu Y; Shimbara S; Nakatani Y; Atsumi G; Kudo I J Biol Chem; 1997 Aug; 272(32):19891-7. PubMed ID: 9242654 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Rho modulates cytokine-induced prostaglandin E2 formation in renal mesangial cells. Petry C; Fritz G; Pfeilschifter J; Huwiler A Biochim Biophys Acta; 2004 Mar; 1636(2-3):108-18. PubMed ID: 15164758 [TBL] [Abstract][Full Text] [Related]
10. Differential stimulation of cytosolic phospholipase A2 by bradykinin in human cystic fibrosis cell lines. Berguerand M; Klapisz E; Thomas G; Humbert L; Jouniaux AM; Olivier JL; Béréziat G; Masliah J Am J Respir Cell Mol Biol; 1997 Oct; 17(4):481-90. PubMed ID: 9376123 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2. Dieter P; Kolada A; Kamionka S; Schadow A; Kaszkin M Cell Signal; 2002 Mar; 14(3):199-204. PubMed ID: 11812647 [TBL] [Abstract][Full Text] [Related]
14. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium. Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935 [TBL] [Abstract][Full Text] [Related]
15. Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. Jaulmes A; Thierry S; Janvier B; Raymondjean M; Maréchal V FASEB J; 2006 Aug; 20(10):1727-9. PubMed ID: 16807371 [TBL] [Abstract][Full Text] [Related]
16. DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs. Knorre A; Wagner M; Schaefer HE; Colledge WH; Pahl HL Biol Chem; 2002 Feb; 383(2):271-82. PubMed ID: 11934265 [TBL] [Abstract][Full Text] [Related]
18. Defective CFTR- β-catenin interaction promotes NF-κB nuclear translocation and intestinal inflammation in cystic fibrosis. Liu K; Zhang X; Zhang JT; Tsang LL; Jiang X; Chan HC Oncotarget; 2016 Sep; 7(39):64030-64042. PubMed ID: 27588407 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors. Pruzanski W; Stefanski E; Vadas P; Kennedy BP; van den Bosch H Biochim Biophys Acta; 1998 May; 1403(1):47-56. PubMed ID: 9622592 [TBL] [Abstract][Full Text] [Related]
20. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. Bhura-Bandali FN; Suh M; Man SF; Clandinin MT J Nutr; 2000 Dec; 130(12):2870-5. PubMed ID: 11110839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]